These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease. Fukutomi M; Toriumi S; Ogoyama Y; Oba Y; Takahashi M; Funayama H; Kario K Catheter Cardiovasc Interv; 2019 Apr; 93(5):E262-E268. PubMed ID: 30244539 [TBL] [Abstract][Full Text] [Related]
3. Readmissions in ST-Elevation Myocardial Infarction and Cardiogenic Shock (from Nationwide Readmission Database). Sud K; Haddadin F; Tsutsui RS; Parashar A; Bandyopadhyay D; Ellis SG; Tuzcu EM; Kapadia S Am J Cardiol; 2019 Dec; 124(12):1841-1850. PubMed ID: 31685215 [TBL] [Abstract][Full Text] [Related]
4. Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease. Iqbal MB; Nadra IJ; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Robinson SD; JACC Cardiovasc Interv; 2017 Jan; 10(1):11-23. PubMed ID: 28057282 [TBL] [Abstract][Full Text] [Related]
5. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy. Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010 [TBL] [Abstract][Full Text] [Related]
6. Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data. Chatterjee S; Kundu A; Mukherjee D; Sardar P; Mehran R; Bashir R; Giri J; Abbott JD Catheter Cardiovasc Interv; 2017 Aug; 90(2):205-212. PubMed ID: 28112470 [TBL] [Abstract][Full Text] [Related]
7. Associations Between Hospital Length of Stay, 30-Day Readmission, and Costs in ST-Segment-Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: A Nationwide Readmissions Database Analysis. Jang SJ; Yeo I; Feldman DN; Cheung JW; Minutello RM; Singh HS; Bergman G; Wong SC; Kim LK J Am Heart Assoc; 2020 Jun; 9(11):e015503. PubMed ID: 32468933 [TBL] [Abstract][Full Text] [Related]
8. Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study. Ibrahim H; Sharma PK; Cohen DJ; Fonarow GC; Kaltenbach LA; Effron MB; Zettler ME; Peterson ED; Wang TY J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982673 [TBL] [Abstract][Full Text] [Related]
9. Frequency of 30-day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock. Atti V; Patel NJ; Kumar V; Tripathi B; Basir MB; Voeltz M; Baber U; Kini AS; Sharma SK; O'Neill WW; Bhatt DL Catheter Cardiovasc Interv; 2019 Aug; 94(2):E67-E77. PubMed ID: 30811833 [TBL] [Abstract][Full Text] [Related]
10. Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials. Elgendy IY; Mahmoud AN; Kumbhani DJ; Bhatt DL; Bavry AA JACC Cardiovasc Interv; 2017 Feb; 10(4):315-324. PubMed ID: 28231899 [TBL] [Abstract][Full Text] [Related]
12. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease. Perera D; Crake T; Lee V Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315 [TBL] [Abstract][Full Text] [Related]
13. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG). Pandey A; McGuire DK; de Lemos JA; Das SR; Berry JD; Brilakis ES; Banerjee S; Marso SP; Barsness GW; Simon DN; Roe M; Goyal A; Kosiborod M; Amsterdam EA; Kumbhani DJ Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):197-205. PubMed ID: 27166210 [TBL] [Abstract][Full Text] [Related]
14. Thirty-Day Readmission Rates, Timing, Causes, and Costs after ST-Segment-Elevation Myocardial Infarction in the United States: A National Readmission Database Analysis 2010-2014. Kim LK; Yeo I; Cheung JW; Swaminathan RV; Wong SC; Charitakis K; Adejumo O; Chae J; Minutello RM; Bergman G; Singh H; Feldman DN J Am Heart Assoc; 2018 Sep; 7(18):e009863. PubMed ID: 30371187 [TBL] [Abstract][Full Text] [Related]
15. Causes and Predictors of 30-Day Readmission in Patients With COVID-19 and ST-Segment-Elevation Myocardial Infarction in the United States: A Nationwide Readmission Database Analysis. Patel KN; Majmundar M; Khawaja T; Doshi R; Kaur A; Mehta H; Gupta K J Am Heart Assoc; 2023 Aug; 12(15):e029738. PubMed ID: 37489728 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes in myocardial infarction and multivessel disease after a cardiac rehabilitation programme: Partial versus complete revascularization. Mori Junco R; Dalmau Gonzalez-Gallarza R; Castro Conde A; González Fernandez O; Álvarez Ortega C; Blázquez Bermejo Z; Furuya-Kanamori L; Moreno Gomez R; López de Sa Arreses E Arch Cardiovasc Dis; 2017 Apr; 110(4):234-241. PubMed ID: 28082243 [TBL] [Abstract][Full Text] [Related]
17. Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States: An NCDR Research to Practice Project. Secemsky EA; Butala N; Raja A; Khera R; Wang Y; Curtis JP; Maddox TM; Virani SS; Armstrong EJ; Shunk KA; Brindis RG; Bhatt D; Yeh RW JAMA Cardiol; 2021 May; 6(5):574-580. PubMed ID: 33146666 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of in-hospital staged revascularization versus culprit-only intervention for patients with ST-segment elevation myocardial infarction and multivessel disease. Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Dai J; Tian J Coron Artery Dis; 2019 May; 30(3):188-195. PubMed ID: 30724818 [TBL] [Abstract][Full Text] [Related]
19. Discharge Against Medical Advice After Percutaneous Coronary Intervention in the United States. Kwok CS; Bell M; Anderson HV; Al Shaibi K; Gulati R; Potts J; Rashid M; Kontopantelis E; Bagur R; Mamas MA JACC Cardiovasc Interv; 2018 Jul; 11(14):1354-1364. PubMed ID: 30025729 [TBL] [Abstract][Full Text] [Related]
20. Outcomes after culprit-only percutaneous coronary intervention for multivessel disease during ST-segment elevation myocardial infarction: a comparison of registry and clinical trial outcomes. Jackson MWP; Austin D; Swanson N; Williams PD; Muir DF; Hall JA; Wright RA; Sutton AGC; Carter J; de Belder MA Coron Artery Dis; 2018 Nov; 29(7):564-572. PubMed ID: 29944476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]